Cargando…

Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma

The histopathological and molecular heterogeneity of glioblastomas represents a major obstacle for effective therapies. Glioblastomas do not develop autonomously, but evolve in a unique environment that adapts to the growing tumour mass and contributes to the malignancy of these neoplasms. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Bougnaud, Sébastien, Golebiewska, Anna, Oudin, Anaïs, Keunen, Olivier, Harter, Patrick N., Mäder, Lisa, Azuaje, Francisco, Fritah, Sabrina, Stieber, Daniel, Kaoma, Tony, Vallar, Laurent, Brons, Nicolaas H.C., Daubon, Thomas, Miletic, Hrvoje, Sundstrøm, Terje, Herold-Mende, Christel, Mittelbronn, Michel, Bjerkvig, Rolf, Niclou, Simone P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077988/
https://www.ncbi.nlm.nih.gov/pubmed/27049916
http://dx.doi.org/10.18632/oncotarget.7454
_version_ 1782462282981179392
author Bougnaud, Sébastien
Golebiewska, Anna
Oudin, Anaïs
Keunen, Olivier
Harter, Patrick N.
Mäder, Lisa
Azuaje, Francisco
Fritah, Sabrina
Stieber, Daniel
Kaoma, Tony
Vallar, Laurent
Brons, Nicolaas H.C.
Daubon, Thomas
Miletic, Hrvoje
Sundstrøm, Terje
Herold-Mende, Christel
Mittelbronn, Michel
Bjerkvig, Rolf
Niclou, Simone P.
author_facet Bougnaud, Sébastien
Golebiewska, Anna
Oudin, Anaïs
Keunen, Olivier
Harter, Patrick N.
Mäder, Lisa
Azuaje, Francisco
Fritah, Sabrina
Stieber, Daniel
Kaoma, Tony
Vallar, Laurent
Brons, Nicolaas H.C.
Daubon, Thomas
Miletic, Hrvoje
Sundstrøm, Terje
Herold-Mende, Christel
Mittelbronn, Michel
Bjerkvig, Rolf
Niclou, Simone P.
author_sort Bougnaud, Sébastien
collection PubMed
description The histopathological and molecular heterogeneity of glioblastomas represents a major obstacle for effective therapies. Glioblastomas do not develop autonomously, but evolve in a unique environment that adapts to the growing tumour mass and contributes to the malignancy of these neoplasms. Here, we show that patient-derived glioblastoma xenografts generated in the mouse brain from organotypic spheroids reproducibly give rise to three different histological phenotypes: (i) a highly invasive phenotype with an apparent normal brain vasculature, (ii) a highly angiogenic phenotype displaying microvascular proliferation and necrosis and (iii) an intermediate phenotype combining features of invasion and vessel abnormalities. These phenotypic differences were visible during early phases of tumour development suggesting an early instructive role of tumour cells on the brain parenchyma. Conversely, we found that tumour-instructed stromal cells differentially influenced tumour cell proliferation and migration in vitro, indicating a reciprocal crosstalk between neoplastic and non-neoplastic cells. We did not detect any transdifferentiation of tumour cells into endothelial cells. Cell type-specific transcriptomic analysis of tumour and endothelial cells revealed a strong phenotype-specific molecular conversion between the two cell types, suggesting co-evolution of tumour and endothelial cells. Integrative bioinformatic analysis confirmed the reciprocal crosstalk between tumour and microenvironment and suggested a key role for TGFβ1 and extracellular matrix proteins as major interaction modules that shape glioblastoma progression. These data provide novel insight into tumour-host interactions and identify novel stroma-specific targets that may play a role in combinatorial treatment strategies against glioblastoma.
format Online
Article
Text
id pubmed-5077988
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-50779882016-10-28 Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma Bougnaud, Sébastien Golebiewska, Anna Oudin, Anaïs Keunen, Olivier Harter, Patrick N. Mäder, Lisa Azuaje, Francisco Fritah, Sabrina Stieber, Daniel Kaoma, Tony Vallar, Laurent Brons, Nicolaas H.C. Daubon, Thomas Miletic, Hrvoje Sundstrøm, Terje Herold-Mende, Christel Mittelbronn, Michel Bjerkvig, Rolf Niclou, Simone P. Oncotarget Research Paper The histopathological and molecular heterogeneity of glioblastomas represents a major obstacle for effective therapies. Glioblastomas do not develop autonomously, but evolve in a unique environment that adapts to the growing tumour mass and contributes to the malignancy of these neoplasms. Here, we show that patient-derived glioblastoma xenografts generated in the mouse brain from organotypic spheroids reproducibly give rise to three different histological phenotypes: (i) a highly invasive phenotype with an apparent normal brain vasculature, (ii) a highly angiogenic phenotype displaying microvascular proliferation and necrosis and (iii) an intermediate phenotype combining features of invasion and vessel abnormalities. These phenotypic differences were visible during early phases of tumour development suggesting an early instructive role of tumour cells on the brain parenchyma. Conversely, we found that tumour-instructed stromal cells differentially influenced tumour cell proliferation and migration in vitro, indicating a reciprocal crosstalk between neoplastic and non-neoplastic cells. We did not detect any transdifferentiation of tumour cells into endothelial cells. Cell type-specific transcriptomic analysis of tumour and endothelial cells revealed a strong phenotype-specific molecular conversion between the two cell types, suggesting co-evolution of tumour and endothelial cells. Integrative bioinformatic analysis confirmed the reciprocal crosstalk between tumour and microenvironment and suggested a key role for TGFβ1 and extracellular matrix proteins as major interaction modules that shape glioblastoma progression. These data provide novel insight into tumour-host interactions and identify novel stroma-specific targets that may play a role in combinatorial treatment strategies against glioblastoma. Impact Journals LLC 2016-03-25 /pmc/articles/PMC5077988/ /pubmed/27049916 http://dx.doi.org/10.18632/oncotarget.7454 Text en Copyright: © 2016 Bougnaud et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Bougnaud, Sébastien
Golebiewska, Anna
Oudin, Anaïs
Keunen, Olivier
Harter, Patrick N.
Mäder, Lisa
Azuaje, Francisco
Fritah, Sabrina
Stieber, Daniel
Kaoma, Tony
Vallar, Laurent
Brons, Nicolaas H.C.
Daubon, Thomas
Miletic, Hrvoje
Sundstrøm, Terje
Herold-Mende, Christel
Mittelbronn, Michel
Bjerkvig, Rolf
Niclou, Simone P.
Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma
title Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma
title_full Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma
title_fullStr Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma
title_full_unstemmed Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma
title_short Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma
title_sort molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077988/
https://www.ncbi.nlm.nih.gov/pubmed/27049916
http://dx.doi.org/10.18632/oncotarget.7454
work_keys_str_mv AT bougnaudsebastien molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma
AT golebiewskaanna molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma
AT oudinanais molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma
AT keunenolivier molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma
AT harterpatrickn molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma
AT maderlisa molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma
AT azuajefrancisco molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma
AT fritahsabrina molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma
AT stieberdaniel molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma
AT kaomatony molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma
AT vallarlaurent molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma
AT bronsnicolaashc molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma
AT daubonthomas molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma
AT miletichrvoje molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma
AT sundstrømterje molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma
AT heroldmendechristel molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma
AT mittelbronnmichel molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma
AT bjerkvigrolf molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma
AT niclousimonep molecularcrosstalkbetweentumourandbrainparenchymainstructshistopathologicalfeaturesinglioblastoma